Wet‐AMD on a Chip: Modeling Outer Blood‐Retinal Barrier In Vitro

Choroidal neovascularization (CNV) in the retinal pigment epithelium (RPE)–choroid complex constituting outer blood retinal barrier (oBRB) is a critical pathological step in various ophthalmic diseases, which results in blindness, such as wet type age‐related macula degeneration. Current in vitro experimental models using petri dishes or transwell are unable to study CNV morphogenesis. Here, a unique organotypic eye‐on‐a‐chip model is described that mimics the RPE–choroid complex in vitro. This model consists of an RPE monolayer and adjacent perfusable blood vessel network, which is supporting barrier function of oBRB. The intact barrier function of the RPE‐choroid complex is reconstituted while maintaining important structural features. Further, this model can successfully mimic the pathogenesis of CNV especially in terms of morphogenesis, which is penetrating angiogenic sprouts from pre‐existing choroidal vessels that result in breakdown of RPE monolayer. The alleviation of the pathological angiogenesis can be modeled with bevacizumab, a clinical drug for CNV treatment. It is believed that this model can be used to aid in the development of advanced in vitro eye drug evaluation in conjunction with animal models.

[1]  D. Archer,et al.  The histochemistry of drusen. , 1971, American journal of ophthalmology.

[2]  S. Ryan,et al.  Subretinal neovascularization. Natural history of an experimental model. , 1982, Archives of ophthalmology.

[3]  A C Bird,et al.  Bruch's membrane change with age. , 1992, The British journal of ophthalmology.

[4]  D. Shima,et al.  The Mouse Gene for Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.

[5]  Karl Matter,et al.  The tight junction protein ZO‐1 and an interacting transcription factor regulate ErbB‐2 expression , 2000, The EMBO journal.

[6]  P. Campochiaro,et al.  Retinal and choroidal neovascularization , 2000, Journal of cellular physiology.

[7]  G. Chader.  PEDF: Raising both hopes and questions in controlling angiogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Schlosshauer,et al.  In vitro model of the outer blood-retina barrier. , 2004, Brain research. Brain research protocols.

[9]  Marco A Zarbin,et al.  Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.

[10]  J. Cunha-Vaz.  The blood-retinal barriers , 1976, Documenta Ophthalmologica.

[11]  Philip J Rosenfeld,et al.  Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. , 2005, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[12]  G. Seigel,et al.  EVALUATION OF IN VITRO EFFECTS OF BEVACIZUMAB (AVASTIN) ON RETINAL PIGMENT EPITHELIAL, NEUROSENSORY RETINAL, AND MICROVASCULAR ENDOTHELIAL CELLS , 2006, Retina.

[13]  H. Kang,et al.  Antiangiogenic Effect of Deguelin on Choroidal Neovascularization , 2008, Journal of Pharmacology and Experimental Therapeutics.

[14]  Z. Ablonczy,et al.  Pigment Epithelium-derived Factor Maintains Retinal Pigment Epithelium Function by Inhibiting Vascular Endothelial Growth Factor-R2 Signaling through γ-Secretase* , 2009, The Journal of Biological Chemistry.

[15]  Tharathorn Rimchala,et al.  Surface‐Treatment‐Induced Three‐Dimensional Capillary Morphogenesis in a Microfluidic Platform , 2009, Advanced materials.

[16]  A. Lee,et al.  Engineering microscale cellular niches for three-dimensional multicellular co-cultures. , 2009, Lab on a chip.

[17]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[18]  Yueying Liu,et al.  Human retinal pigment epithelium cells as functional models for the RPE in vivo. , 2011, Investigative ophthalmology & visual science.

[19]  I. Bhutto,et al.  Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. , 2012, Molecular aspects of medicine.

[20]  P. D'Amore,et al.  Molecular regulation of vascular endothelial growth factor expression in the retinal pigment epithelium , 2012, Molecular vision.

[21]  Ali Khademhosseini,et al.  Directed endothelial cell morphogenesis in micropatterned gelatin methacrylate hydrogels. , 2012, Biomaterials.

[22]  Naoki Nishishita,et al.  Pigment Epithelium-Derived Factor Secreted from Retinal Pigment Epithelium Facilitates Apoptotic Cell Death of iPSC , 2013, Scientific Reports.

[23]  Duc-Huy T Nguyen,et al.  Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro , 2013, Proceedings of the National Academy of Sciences.

[24]  Hyunjae Lee,et al.  Engineering of functional, perfusable 3D microvascular networks on a chip. , 2013, Lab on a chip.

[25]  Noo Li Jeon,et al.  Microvasculature: An essential component for organ-on-chip systems , 2014 .

[26]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[27]  J. Flach,et al.  The Vascular Endothelial Growth Factor (vegf) Basal and Apical Regulation of Vegf-a and Placenta Growth Factor in the Rpe/choroid and Primary Rpe , 2022 .

[28]  Noo Li Jeon,et al.  Engineering of a Biomimetic Pericyte-Covered 3D Microvascular Network , 2015, PloS one.

[29]  D. Huh,et al.  Organs-on-chips at the frontiers of drug discovery , 2015, Nature Reviews Drug Discovery.

[30]  Noo Li Jeon,et al.  Interstitial flow regulates the angiogenic response and phenotype of endothelial cells in a 3D culture model. , 2016, Lab on a chip.